Are peptides the next GLP-1? The market says yes. Science is less certain

Reviewed by Dr Dan Reardon, NHS A&E doctor with a specialist interest in metabolic health. Published 23rd April 2026. Most peptides being sold in the wellness market today have not been through the clinical trials required to prove they produce a meaningful effect in humans. A small number (most notably the GLP-1 class and the…

ByJon LipseyApril 23, 20260Comments

HEALTH Explainer

CJC-1295: how it works, what the evidence shows

CJC-1295 has one of the strongest published human clinical records of any wellness-market peptide, a Phase 2 trial that was discontinued after a participant death, and a December 2024 FDA advisory committee vote against allowing it into the regulated compounding system. The gap between the science and the regulatory verdict is where its current safety…

ByJon LipseyJanuary 19, 20260Comments

HEALTH Explainer

Peptide Therapy: What It Is, How It Works, and is it Safe or Legal?

Peptide therapy has become a buzzword in high-performance health, with claims ranging from faster recovery and better sleep to improved fat loss, hormonal balance, and even longer lifespan. But while its popularity is growing among athletes, biohackers, and anti-aging enthusiasts, there’s still a lot of confusion around what peptide therapy actually is — and whether…

ByJon LipseyJanuary 17, 20260Comments

HEALTH Explainer

What Is Peptide Therapy? Exploring the Science, Benefits and Legal Status

Peptides are one of the most exciting developments in preventative and performance-based health. But with all the hype around fat-burning peptides, anti-aging injections, and recovery boosters, a fundamental question still needs answering: what is peptide therapy? This post gives you a clear, science-based overview of what peptide therapy is, how it works, who it’s for,…

ByJon LipseyDecember 13, 20240Comments

HEALTH Explainer

BPC-157 side effects: what the evidence actually shows

BPC-157 is one of the most discussed peptides on the wellness internet and one of the least documented in the human clinical literature, and the gap between those two facts is where most of its safety story sits. The compound has been studied in laboratories for more than thirty years. It has been studied in…

ByJon LipseyNovember 6, 20240Comments

Newsletter

Sign Up to Our Newsletter